Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pazos, P.
Right arrow Articles by Molinolo, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pazos, P.
Right arrow Articles by Molinolo, A. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 529-531, Copyright © 1998 by Oxford University Press

ARTICLES

Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N- nitrosourea (MNU) induced mammary tumors in BALB/c mice

P Pazos, C Lanari, P Elizalde, F Montecchia, EH Charreau and AA Molinolo
Instituto de Biologia y Medicina Experimental, Academia Nacional de Medicina, Buenos Aires, Argentina.

The promoter effect of medroxyprogesterone acetate (MPA) on mammary carcinogenesis in female BALB/c mice was investigated using methylnitrosourea (MNU) as initiator. Nine out of 43 animals developed mammary carcinomas in the group treated with MNU (50 mg/kg) and MPA (administration of 40 mg every 3 months) starting 1 week after MNU administration. No tumors appeared in controls receiving only MNU or MPA during the time course of the experiment (9 months). The tumors were lobular adenocarcinomas showing different degrees of squamous differentiation with low or undetectable estrogen and progesterone receptors, and expressing epidermal growth factor receptors. These results support the hypothesis that MPA promotes the growth of MNU induced lesions.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
C. Lanari, C. A Lamb, V. T Fabris, L. A Helguero, R. Soldati, M. C. Bottino, S. Giulianelli, J. P. Cerliani, V. Wargon, and A. Molinolo
The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer
Endocr. Relat. Cancer, June 1, 2009; 16(2): 333 - 350.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Arruvito, S. Giulianelli, A. C. Flores, N. Paladino, M. Barboza, C. Lanari, and L. Fainboim
NK Cells Expressing a Progesterone Receptor Are Susceptible to Progesterone-Induced Apoptosis
J. Immunol., April 15, 2008; 180(8): 5746 - 5753.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Cao, J.-l. Luo, and M. Karin
I{kappa}B kinase {alpha} kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells
PNAS, October 2, 2007; 104(40): 15852 - 15857.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. R. Raimondi, L. Vitale-Cross, P. Amornphimoltham, J. S. Gutkind, and A. Molinolo
Rapid Development of Salivary Gland Carcinomas upon Conditional Expression of K-ras Driven by the Cytokeratin 5 Promoter
Am. J. Pathol., May 1, 2006; 168(5): 1654 - 1665.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
D. Palmieri, D. O. Halverson, T. Ouatas, C. E. Horak, M. Salerno, J. Johnson, W. D. Figg, M. Hollingshead, S. Hursting, D. Berrigan, et al.
Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor-Negative Breast Cancer
J Natl Cancer Inst, May 4, 2005; 97(9): 632 - 642.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Lanari, I. Lüthy, C. A. Lamb, V. Fabris, E. Pagano, L. A. Helguero, N. Sanjuan, S. Merani, and A. A. Molinolo
Five Novel Hormone-responsive Cell Lines Derived from Murine Mammary Ductal Carcinomas: In Vivo and in Vitro Effects of Estrogens and Progestins
Cancer Res., January 1, 2001; 61(1): 293 - 302.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
H. Inano, M. Onoda, K. Suzuki, H. Kobayashi, and K. Wakabayashi
Radiation-induced mammary tumors in virgin and parous rats administered contraceptive steroids, 17{alpha}-ethinylestradiol and norethisterone
Carcinogenesis, May 1, 2000; 21(5): 1043 - 1050.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.